Accessing Duloxetine Information on Synapse: A Step-by-Step Approach

CYMBALTA® (duloxetine hydrochloride) is an oral medication belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) class. Manufactured by Eli Lilly & Co., it was first approved for use in the US in 2004. CYMBALTA® is indicated for the treatment of major depressive disorder, generalized anxiety disorder in adults and pediatric patients 7 years and older, diabetic peripheral neuropathic pain in adults, fibromyalgia in adults and pediatric patients 13 years and older, and chronic musculoskeletal pain in adults. Its chemical name is (+)-(S)-N-methyl-γ-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride, with the empirical formula C18H19NOS•HCl and molecular weight of 333.88. It works by inhibiting serotonin and norepinephrine reuptake. Click on the image below to begin the exploration journey of Duloxetine through the Synapse database!

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!